Health Care

Pfizer COVID-19 vaccine less effective in ages 5-11: study

Two doses of the Pfizer Inc. and BioNTech SE COVID-19 vaccine was protective against severe disease in children aged 5 to 11 during the recent omicron variant surge, but quickly lost most of its ability to prevent infection in the age group, according to a study by New York State researchers.

J&J, distributors finalize $26B opioid settlement

Drugmaker Johnson & Johnson and three major distributors finalized nationwide settlements over their role in the opioid addiction crisis Friday, an announcement that clears the way for $26 billion to flow to nearly every state and local government in the U.S.

Woman appears cured of HIV after umbilical-cord blood transplant

The woman has shown no detectable signs of the human immunodeficiency virus in extensive testing since she stopped antiretroviral treatment in October 2020 following a transplant of stem cells with a rare genetic mutation that blocks HIV invasion, her doctors said.

COVID-19 vaccines for kids under 5: What's coming next?

Parents who thought their children under 5 would have to wait several more months for COVID-19 vaccinations instead just might get them as early as March. Here’s what needs to happen first, and some things to expect if they do become available in the U.S.